To include your compound in the COVID-19 Resource Center, submit it here.

Daiichi Sankyo, Dainippon Sumitomo deal

Dainippon granted Daiichi exclusive rights in Brazil and Venezuela to commercialize antipsychotic Latuda lurasidone ( SM-13496). Daiichi is responsible

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE